The global kidney transplant market is slated to grow on the basis of an exponential increase in kidney disorders coupled with rise in healthcare spending. Kidney transplant is generally the first choice of treatment regarding kidney failure as compared to dialysis for a lifetime.
Kidney transplant emphasizes lower risk of fatalities, better quality of life, lower cost of treatment, and lesser number of dietary restrictions.
The companies operating in the kidney transplant market are working toward incorporation of technological advancements with regards to transplant procedures such as robotic-assisted and laparoscopic kidney transplants considering the minimal post-surgery pain, lesser complications linked with open surgeries, and quicker recovery time.
Various private-public investments are also witnessed, which are focusing on organizing awareness campaigns regarding organ donation.
A kidney transplant is referred to as a surgery involving placement of a healthy kidney from a deceased or living donor into the one whose kidneys are dysfunctional.
The basic functionality of kidneys is that of filtering and removing waste, fluid, and minerals from blood by producing urine. Harmful levels of waste and fluid accumulate in the body on kidneys losing their ability to filter.
This, in turn, can raise the blood pressure and cause end-stage renal disease called kidney failure. The kidneys thus lose close to 90% of their ability of functioning normally then.
The common causes of the end-stage kidney disease constitute diabetes, uncontrolled, chronic high blood pressure, chronic glomerulonephritis (an inflammation and ultimate scarring of tiny filters within kidneys), and polycystic kidney disease.
However, the number of patients requiring a kidney transplant outnumbers the number of organs available. Furthermore, there are ethical issues linked with expansion of donor pool. At times, improper knowledge about kidney transplant is also responsible for the shortage of kidney donors.
For instance, in December 2020, as per a study published in the American Society of Nephrology, 493 kidneys having similar donor characteristics and quality in comparison with the ones transplanted in France (where there are less number of restrictions regarding transplantation practices), could have been utilized to transplant in the U.S.
The study further stated that survival rates for such kidneys were 93% in a year, 68% in 10 years, and 83% in five years. It could thus be inferred that several kidneys with suitable donors in the U.S. are discarded unnecessarily.
Attribute | Detail |
---|---|
Market Drivers |
|
The rise in incidence of kidney disorders around the world is one of the key drivers for kidney transplant market. As per the WHO, more than 2 million individuals contract end-stage kidney diseases every year, which need renal replacement therapy in the form of kidney dialysis/kidney transplantation for staying alive.
Dialysis offers lifeline for the patients who suffer from kidney disorder, kidney transplantation is looked upon as the finest option as it helps in restoration of normal functions of the kidney and improves the quality of life.
However, shortage of organ donors still poses major challenges. As an outcome, the number of patients needing kidney transplantation is growing quicker as compared to availability of the donor organs, thereby exerting tremendous pressure on global kidney transplant market.
MJH Life Sciences, in April 2024, released a consensus statement mentioning that incidence of kidney disease has surpassed the other non-communicable diseases that have been prioritized by the WHO including cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases.
Increase in healthcare expenditure at the global level, rise in disposable incomes, and favorable medical insurance penetration are collectively contributing toward the growth of kidney transplant market.
In the developed economies, increase in per capita healthcare spending extends support to the ongoing technological upgradations in order to enhance the success rates of transplantation of organs. Moreover, developing markets are witnessing rise in expenditure on the complex transplant surgeries.
This is basically due to noticeable research conducted by the private agencies in elevating standards of medical care. It has thus been reported that more number of patients have access to numerous stages of kidney transplantation that include pre-transplant evaluation, immunosuppressive therapy post transplantation, and long-term medical management.
AstraZeneca’s model released in May 2024 has suggested notable cost savings for health systems through early CKD screening as well as treatment in four European countries. The studies presented at ERA Congress lend support to advantages offered by targeted screening along with guideline-directed treatment.
The real-world evidence through DISCOVER CKD has reinforced the vitality of early treatment, whereas survey data from PaCE CKD trial highlights the consequences of CKD on care providers and patients alike.
Continual improvement in access to healthcare is thus expanding the kidney transplant market share.
Attribute | Detail |
---|---|
Leading Region | North America |
As per the latest kidney transplant market analysis, North America held the largest share of kidney transplant landscape in 2023 and the status quo is expected to remain unchanged during the forecast period.
This is attributed to the U.S. witnessing a noticeable increase in demand for kidney transplants. It has been reported that the U.S. also imports the organs owing to a mismatch between demand and supply.
Asia Pacific’s significant kidney transplant market growth is ascribed to rise in the frequency of chronic diseases in China and India, which, in turn, is prompting the governments to opt for organ donation.
The medical technology firms worldwide are also investing in local manufacturing in India and China, which is poised to contribute toward boosting the kidney transplant industry revenue.
The kidney transplant market manufacturers are engaging in inorganic modes of expansion to strengthen their position in the lithotripsy devices landscape.
For instance, in February 2022, Bio-Techne Corporation announced that it had entered into partnership with Thermo Fisher Scientific with the objective of developing and commercializing ExoTRU kidney transplant rejection test through its brand called Exosome Diagnostics.
ExoTRU is referred to as a non-invasive urine-based liquid biopsy assay providing necessary allograft health information to help clinicians in optimizing care of patients undergoing kidney transplant.
Transonic, Sanofi S.A., Organ Recovery Systems, Inc., Pfizer Inc., TransMedics Inc., Novartis AG, Preservation Solutions Inc., B. Braun, Medtronic plc, and Fresenius Medical Care AG & Co. are some of the key players spanning the kidney transplant market statistics.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
Attribute | Detail |
---|---|
Market Size in 2023 | US$ 81.0 Bn |
Market Forecast (Value) in 2034 | US$ 116.4 Bn |
Growth Rate (CAGR) | 3.3% |
Forecast Period | 2024-2034 |
Historical Data Available for | 2020-2022 |
Quantitative Units | US$ Bn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available Upon Request |
Pricing | Available Upon Request |
It was valued at US$ 81.0 Bn in 2023
It is projected to grow at a CAGR of 3.3% from 2024 to 2034
Growing prevalence of kidney diseases and improvement in access to care due to rise in healthcare expenditure
Transplant centers segment accounted for the largest share in 2023
North America was the dominant region in 2023
Transonic, Sanofi S.A., Organ Recovery Systems, Inc., Pfizer Inc., TransMedics Inc., Novartis AG, Preservation Solutions Inc., B. Braun, Medtronic plc, and Fresenius Medical Care AG & Co.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Kidney Transplant Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Kidney Transplant Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Kidney Transplant Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. Living Donor Transplant
6.3.2. Paired Kidney Transplant
6.3.3. Deceased Donor Transplant
6.4. Market Attractiveness Analysis, by Type
7. Global Kidney Transplant Market Analysis and Forecast, by Age Group
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Age Group, 2020-2034
7.3.1. Children
7.3.2. Adults
7.4. Market Attractiveness Analysis, by Age Group
8. Global Kidney Transplant Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Transplant Centers
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Kidney Transplant Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Kidney Transplant Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
10.3.1. Living Donor Transplant
10.3.2. Paired Kidney Transplant
10.3.3. Deceased Donor Transplant
10.4. Market Value Forecast, by Age Group, 2020-2034
10.4.1. Children
10.4.2. Adults
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Specialty Clinics
10.5.3. Transplant Centers
10.5.4. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Age Group
10.7.3. By End-user
10.7.4. By Country
11. Europe Kidney Transplant Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
11.3.1. Living Donor Transplant
11.3.2. Paired Kidney Transplant
11.3.3. Deceased Donor Transplant
11.4. Market Value Forecast, by Age Group, 2020-2034
11.4.1. Children
11.4.2. Adults
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Specialty Clinics
11.5.3. Transplant Centers
11.5.4. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Age Group
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Kidney Transplant Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
12.3.1. Living Donor Transplant
12.3.2. Paired Kidney Transplant
12.3.3. Deceased Donor Transplant
12.4. Market Value Forecast, by Age Group, 2020-2034
12.4.1. Children
12.4.2. Adults
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Specialty Clinics
12.5.3. Transplant Centers
12.5.4. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Age Group
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Kidney Transplant Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
13.3.1. Living Donor Transplant
13.3.2. Paired Kidney Transplant
13.3.3. Deceased Donor Transplant
13.4. Market Value Forecast, by Age Group, 2020-2034
13.4.1. Children
13.4.2. Adults
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Specialty Clinics
13.5.3. Transplant Centers
13.5.4. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Age Group
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Kidney Transplant Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
14.3.1. Living Donor Transplant
14.3.2. Paired Kidney Transplant
14.3.3. Deceased Donor Transplant
14.4. Market Value Forecast, by Age Group, 2020-2034
14.4.1. Children
14.4.2. Adults
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Specialty Clinics
14.5.3. Transplant Centers
14.5.4. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Age Group
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Transonic
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Sanofi S.A.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Organ Recovery Systems, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Pfizer Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. TransMedics Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Novartis AG
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Preservation Solutions Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. B. Braun
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Medtronic plc
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Fresenius Medical Care AG & Co.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Kidney Transplant Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 02: Global Kidney Transplant Market Size (US$ Bn) Forecast, by Age Group, 2020-2034
Table 03: Global Kidney Transplant Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Kidney Transplant Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Kidney Transplant Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Kidney Transplant Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 07: North America Kidney Transplant Market Size (US$ Bn) Forecast, by Age Group, 2020-2034
Table 08: North America Kidney Transplant Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Kidney Transplant Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Kidney Transplant Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 11: Europe Kidney Transplant Market Size (US$ Bn) Forecast, by Age Group, 2020-2034
Table 12: Europe Kidney Transplant Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Kidney Transplant Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Kidney Transplant Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 15: Asia Pacific Kidney Transplant Market Size (US$ Bn) Forecast, by Age Group, 2020-2034
Table 16: Asia Pacific Kidney Transplant Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Kidney Transplant Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Kidney Transplant Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 19: Latin America Kidney Transplant Market Size (US$ Bn) Forecast, by Age Group, 2020-2034
Table 20: Latin America Kidney Transplant Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Kidney Transplant Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Kidney Transplant Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 23: Middle East & Africa Kidney Transplant Market Size (US$ Bn) Forecast, by Age Group, 2020-2034
Table 24: Middle East & Africa Kidney Transplant Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Kidney Transplant Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Kidney Transplant Market Revenue (US$ Bn), by Type, 2023
Figure 03: Global Kidney Transplant Market Value Share, by Type, 2023
Figure 04: Global Kidney Transplant Market Revenue (US$ Bn), by Age Group, 2023
Figure 05: Global Kidney Transplant Market Value Share, by Age Group, 2023
Figure 06: Global Kidney Transplant Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Kidney Transplant Market Value Share, by End-user, 2023
Figure 08: Global Kidney Transplant Market Value Share, by Region, 2023
Figure 09: Global Kidney Transplant Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Kidney Transplant Market Value Share Analysis, by Type, 2023 and 2034
Figure 11: Global Kidney Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Kidney Transplant Market Value Share Analysis, by Age Group, 2023 and 2034
Figure 13: Global Kidney Transplant Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 14: Global Kidney Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Kidney Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Kidney Transplant Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Kidney Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Kidney Transplant Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Kidney Transplant Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Kidney Transplant Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Kidney Transplant Market Value Share Analysis, by Type, 2023 and 2034
Figure 22: North America Kidney Transplant Market Value Share Analysis, by Age Group, 2023 and 2034
Figure 23: North America Kidney Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Kidney Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Kidney Transplant Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 26: North America Kidney Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Kidney Transplant Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Kidney Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Kidney Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Kidney Transplant Market Value Share Analysis, by Type, 2023 and 2034
Figure 31: Europe Kidney Transplant Market Value Share Analysis, by Age Group, 2023 and 2034
Figure 32: Europe Kidney Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Kidney Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Kidney Transplant Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 35: Europe Kidney Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Kidney Transplant Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Kidney Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Kidney Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Kidney Transplant Market Value Share Analysis, by Type, 2023 and 2034
Figure 40: Asia Pacific Kidney Transplant Market Value Share Analysis, by Age Group, 2023 and 2034
Figure 41: Asia Pacific Kidney Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Kidney Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Kidney Transplant Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 44: Asia Pacific Kidney Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Kidney Transplant Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Kidney Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Kidney Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Kidney Transplant Market Value Share Analysis, by Type, 2023 and 2034
Figure 49: Latin America Kidney Transplant Market Value Share Analysis, by Age Group, 2023 and 2034
Figure 50: Latin America Kidney Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Kidney Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Kidney Transplant Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 53: Latin America Kidney Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Kidney Transplant Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Kidney Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Kidney Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Kidney Transplant Market Value Share Analysis, by Type, 2023 and 2034
Figure 58: Middle East & Africa Kidney Transplant Market Value Share Analysis, by Age Group, 2023 and 2034
Figure 59: Middle East & Africa Kidney Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Kidney Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Kidney Transplant Market Attractiveness Analysis, by Age Group, 2024-2034
Figure 62: Middle East & Africa Kidney Transplant Market Attractiveness Analysis, by End-user, 2024-2034